Group One Trading, L.P. Cel Sci Corp Transaction History

Group One Trading, L.P.

$2.2 Billion
Q1 2025

A detailed history of Group One Trading, L.P. transactions in Cel Sci Corp stock. As of the latest transaction made, Group One Trading, L.P. holds 33,599 shares of CVM stock, worth $76,941. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,599

Previous 31,899 5.33%

Holding current value

$76,941

Previous $12,000 41.67%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$0.23 - $0.45 $391 - $765	1,700 Added 5.33%	33,599 $7,000
Q4 2024 Feb 14, 2025	BUY	$0.4 - $1.11 $8,062 - $22,372	20,155 Added 171.62%	31,899 $12,000
Q3 2024 Nov 14, 2024	SELL	$1.05 - $1.5 $12,072 - $17,247	-11,498 Reduced 49.47%	11,744 $12,000
Q2 2024 Aug 14, 2024	SELL	$1.11 - $1.85 $19,649 - $32,748	-17,702 Reduced 43.23%	23,242 $26,000
Q1 2024 May 10, 2024	SELL	$1.63 - $3.08 $48,508 - $91,660	-29,760 Reduced 42.09%	40,944 $78,000
Q4 2023 Feb 14, 2024	BUY	$1.07 - $3.07 $54,572 - $156,576	51,002 Added 258.87%	70,704 $192,000
Q3 2023 Nov 09, 2023	SELL	$1.17 - $2.86 $81,980 - $200,397	-70,069 Reduced 78.05%	19,702 $24,000
Q2 2023 Aug 09, 2023	SELL	$2.11 - $2.83 $207,904 - $278,848	-98,533 Reduced 52.33%	89,771 $216,000
Q1 2023 May 12, 2023	SELL	$2.17 - $3.13 $18,781 - $27,090	-8,655 Reduced 4.39%	188,304 $436,000
Q4 2022 Feb 09, 2023	SELL	$1.99 - $3.52 $47,445 - $83,923	-23,842 Reduced 10.8%	196,959 $462,000
Q3 2022 Nov 09, 2022	SELL	$3.09 - $5.23 $9,968 - $16,871	-3,226 Reduced 1.44%	220,801 $682,000
Q2 2022 Aug 11, 2022	BUY	$2.58 - $4.99 $238,123 - $460,557	92,296 Added 70.06%	224,027 $1.01 Million
Q1 2022 May 12, 2022	BUY	$3.93 - $7.7 $173,556 - $340,047	44,162 Added 50.43%	131,731 $518,000
Q4 2021 Feb 11, 2022	BUY	$7.1 - $12.82 $132,308 - $238,900	18,635 Added 27.03%	87,569 $622,000
Q3 2021 Nov 12, 2021	SELL	$7.64 - $12.49 $720,268 - $1.18 Million	-94,276 Reduced 57.76%	68,934 $758,000
Q2 2021 Aug 10, 2021	BUY	$8.68 - $27.49 $1.42 Million - $4.49 Million	163,210 New	163,210 $1.42 Million
Q3 2019 Nov 12, 2019	SELL	$6.0 - $9.6 $138,660 - $221,856	-23,110 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$3.77 - $8.67 $72,044 - $165,683	19,110 Added 477.75%	23,110 $194,000
Q1 2019 May 13, 2019	BUY	$2.58 - $3.54 $10,320 - $14,160	4,000 New	4,000 $14,000

Others Institutions Holding CVM

# of Institutions

Shares Held

7.55M

Call Options Held

73.8K

Put Options Held

106K

View Full List

About CEL SCI CORP

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $99.3M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

More about CVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Cel Sci Corp Transaction History